The Copolymer P(HEMA-co-SS) Binds Gluten and Reduces Immune Response in Gluten-Sensitized Mice and Human Tissues-Reference-Cited by-同舟云学术

The Copolymer P(HEMA-co-SS) Binds Gluten and Reduces Immune Response in Gluten-Sensitized Mice and Human Tissues

Published:2012-02 Issue:2 Volume:142 Page:316-325.e12
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Pinier Maud,Fuhrmann Gregor,Galipeau Heather J.,Rivard Nathalie,Murray Joseph A.,David Chella S.,Drasarova Hana,Tuckova Ludmila,Leroux Jean–Christophe,Verdu Elena F.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference55 articles.

1. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study;Fasano;Arch Intern Med,2003

2. Prevalence of celiac disease among children in Finland;Maki;N Engl J Med,2003

3. Seroprevalence, correlates, and characteristics of undetected coeliac disease in England;West;Gut,2003

4. Coeliac disease: dissecting a complex inflammatory disorder;Sollid;Nat Rev Immunol,2002

5. Replication of celiac disease UK genome-wide association study results in US population;Garner;Hum Mol Genet,2009

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How Future Pharmacologic Therapies for Celiac Disease Will Complement the Gluten-Free Diet;Gastroenterology;2024-06

2. Potential therapeutic options for celiac Disease: An update on Current evidence from Gluten-Free diet to cell therapy;International Immunopharmacology;2024-05

3. From an understanding of etiopathogenesis to novel therapies—what is new in the treatment of celiac disease?;Frontiers in Pharmacology;2024-04-18

4. Putative therapeutic targets in celiac disease;Pediatric and Adult Celiac Disease;2024

5. Emerging Pharmaceutical Therapies to Address the Inadequacy of a Gluten-Free Diet for Celiac Disease;Pharmaceuticals;2023-12-20